ABG Analytics logo
Get updates

Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 04/09/2021
Closing price: 268.17
Support price level: $258.18
Resistance price level: $289.24
Relative strength index (14-day RSI) 51.3
Beta 0.98
  • With a -15.4 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.

  • Down 3.8 percent, BIIB is one of this week's biggest decliners.

  • BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 43.7%.

  • Volatility is forecast to fall over the next month.

  • Price crossed below 50-day moving average this week - a bearish signal.

Low High Price as % of Range
$236.26 $355.63 31.0%
200 day 50 day 20 day 10 day
$269.13 $271.75 $269.88 $273.87
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
44.1% 44.1% 43.7% 44.6%
There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than:
  • 11.9% in the next week.

  • 25.2% in the next month.

  • 108.4% in the next year.